New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications.

Related Keywords

Justin Eyquem ,Jonathan Esensten ,Jennifer Doudna ,Emily Henderson ,Alex Marson ,Institute Of Genomic Immunology ,Division Of Hematology ,Gladstone Institutes ,Genomic Immunology ,Nature Biotechnology ,Brian Shy ,Crispr ,Biotechnology ,Flood ,Blood Cancer ,Dancer ,Cas9 ,Fell ,Na ,Nzyme ,Gene ,Genes ,Enome ,Enomic ,Mmunology ,Living Cells ,Manufacturing ,Medicine ,Olecule ,Multiple Myeloma ,Myeloma ,Next Generation ,Research ,Herapeutics ,